Drug Testing | Addiction Professional Magazine Skip to content Skip to navigation

Drug Testing

Opioid adulterants now affecting cocaine supply

December 18, 2017  |  Gary A. Enos, Editor
news
Reports from federal officials in Florida raise concerns about the potential deadliness of the cocaine supply.

Cocaine prominent in Florida report on drug deaths

December 4, 2017  |  Gary A. Enos, Editor
news
According to a state of Florida report, deaths involving and caused by cocaine showed significant increases from 2015 to 2016.

Dominion Diagnostics celebrates 20 years in business

November 29, 2017  |  Tom Valentino, Senior Editor
news
The drug monitoring solutions and clinical information provider for addiction treatment and behavioral health facilities has grown to 300 employees and three facilities.

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Research seeks deeper understanding of how cocaine influences HIV

October 9, 2017  |  Gary A. Enos, Editor
news
A five-year research project could lead to more effective biomarkers for cocaine use and new therapeutic strategies for users with or without HIV.

Nearly all Ohio overdose deaths in early 2017 involved fentanyl

September 1, 2017  |  Gary A. Enos, Editor
news
A study found that fentanyl and its analogs were detected in more than 90% of the fatal overdoses in 24 Ohio counties in the first two months of this year.

Workers' compensation data shows slowing of long-term opioid prescribing

August 4, 2017  |  Gary A. Enos, Editor
news
Newly released data suggest that in a number of states, fewer injured workers are receiving long-term prescriptions for opioids.

Massachusetts case complicates decision-making on workplace marijuana testing

August 1, 2017  |  Gary A. Enos, Editor
article
The business community nationally is closely watching a Massachusetts case in which the state's highest court has affirmed an employee's right to use marijuana for medical purposes.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
article
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

Significant prevalence of gabapentin misuse seen in pain patients

August 5, 2016  |  Gary A. Enos, Editor
news
Data presented this week at a national scientific meeting indicate that a significant number of prescription opioid users are misusing the anti-seizure medication gabapentin.

Testing company launches trial in screening for genetic variables in drug response

July 22, 2016  |  Gary A. Enos, Editor
news
InSource Diagnostics is recruiting patients for a study employing urine testing to help determine which patients have a genetic mutation affecting response to drugs such as opioids.

Companies struggle to interpret marijuana test results

June 24, 2016  |  Alison Knopf, Contributing Writer
article
The inability of conventional drug testing to evaluate marijuana impairment creates uncertainty in the workplace testing environment.

Pages

Subscribe to Drug Testing